Drug Search Results

Broxuridine

Alternative Names: broxuridine
Latest Update: 2024-05-09
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Broxuridine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Prostate Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
NCI-2012-02297	P2	Completed	Prostate Cancer	2002-06-01

Recent News Events

Date	Type	Title
05/09/2024	PubMed	MDPV (3,4-methylenedioxypyrovalerone) administered to mice during development of the central nervous system produces persistent learning and memory impairments.
04/26/2024	PubMed	Identification and expression analysis of two steamer-like retrotransposons in the Chilean blue mussel (Mytilus chilensis).
04/03/2024	PubMed	Effects of combined use of ribociclib with PARP1 inhibitor on cell kinetics in breast cancer.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions